← Open Payments lookup

SCOTT SCHNEIDERMAN: Open Payments

NPI 1073693289 · MONTEREY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,173 in 41 payments from 20 companies in 2025. Trend: 2023 $1,744 · 2024 $1,215 · 2025 $1,173

Food & beverage: $1,173
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.2$232
Bard Peripheral Vascular, Inc.1$165
ABBVIE INC.13$144
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$76
Novartis Pharmaceuticals Corporation2$61
Lundbeck LLC2$60
Collegium Pharmaceutical, Inc.3$58
Otsuka Pharmaceutical Development & Commercialization, Inc.2$47
Edwards Lifesciences Corporation1$35
Novo Nordisk Inc1$34

Products named: JARDIANCE, Venclose Maven Catheter, REXULTI, VRAYLAR, CAPLYTA, LEQVIO, Belbuca, UBRELVY.

Industry payments across CA — which companies pay providers there.